A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope
NCT02530970 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1025
Last updated 2023-07-21
Summary
The objective of the SECURE Study is to actively gather additional information on the use of the CorMatrix® CanGaroo ECM® Envelope in a post market observational study.
Conditions
Sponsors & Collaborators
-
Elutia Inc.
lead INDUSTRY
Principal Investigators
-
Andrew Green · CorMatrix Cardiovascular, Inc.
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2017-12-31
- Completion
- 2018-04-30
Countries
- United States
Study Locations
More Related Trials
-
CardioSeq: Impact of WGS in Individuals With CVD
NCT05656183 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Identification of Genetic Markers Modulating Rhythmic Risk Among Patients With Severe Cardiomyopathy
NCT02852018 ·Status: COMPLETED
-
Early Detection of Coronary Artery Disease by Polygenic and Metabolic Risk Scoring
NCT04604353 ·Status: COMPLETED ·Phase: NA
-
Metagenomics and Integrative Systems Medicine of Cardiometabolic Diseases
NCT02059538 ·Status: UNKNOWN ·Phase: NA
-
Investigation of Genetic Risk of Cardiovascular Disease in Prospective Cohort Study
NCT00262691 ·Status: UNKNOWN
-
Prediction of Primary Cardiovascular Events Using the Multimarker Approach
NCT05704569 ·Status: COMPLETED
-
Registry for Mayo Clinic Adult Congenital Heart Disease Control Population
NCT05773300 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Investigation of GENetic Factors in Cardiovascular and Immune-related Traits and Diseases Using a BIOresource of Healthy Volunteers (GENBIO)
NCT04931498 ·Status: ACTIVE_NOT_RECRUITING
-
Patient-Reported Preferences Affecting Revascularization Decisions
NCT02272062 ·Status: COMPLETED ·Phase: NA
-
Personal Genomics for Preventive Cardiology
NCT01406808 ·Status: COMPLETED ·Phase: NA
-
Genetic Risk Stratification for Primary Prevention of CAD in Men and Pre & Post-menopausal Women
NCT05169840 ·Status: UNKNOWN
-
Self-Scored Cardiovascular Disease Risk Appraisal
NCT00005529 ·Status: COMPLETED
-
Multi-omics Merge for Ensemble Subtyping for Atherosclerotic Cardiovascular Disease
NCT06471803 ·Status: NOT_YET_RECRUITING
-
Natural History Study for Charcot Marie Tooth Disease
NCT05902351 ·Status: RECRUITING
-
Whole Genome Association Study to Identify and Validate Genes for Restenosis: CardioGene Validation Proposal
NCT00589810 ·Status: COMPLETED
-
Coronary Artery Calcium, Exercise Tests, and CHD Outcome
NCT00005562 ·Status: COMPLETED
-
Metabolomics, Genomics and Nutrition for Cardiovascular Disease Precision Medicine
NCT05706519 ·Status: UNKNOWN
-
Evaluating Electrocardiogram (ECG) Abnormalities From Young Adulthood Through Middle Age
NCT00556751 ·Status: COMPLETED
-
Inflammation as a Predictor in Cardioversion of Atrial Fibrillation
NCT00590525 ·Status: COMPLETED
-
Epigenetic Reprogramming of Monocytes in Patients With Coronary Atherosclerosis
NCT02393768 ·Status: COMPLETED
-
Inflammation Markers Over Time in Cardiovascular Disease
NCT00005692 ·Status: COMPLETED
-
Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio)
NCT00005260 ·Status: COMPLETED
-
Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)
NCT01117506 ·Status: COMPLETED
-
Genetic Predisposition of Coronary Artery Disease -- The COROGENE-Study
NCT00417534 ·Status: UNKNOWN
-
Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)
NCT06960902 ·Status: RECRUITING ·Phase: NA